1672-8629
2009 Issue 2
..............page:118-120
..............page:121-123
..............page:124-126
Expedited Reporting Criteria Part One: Expectedness Determination
shefali saini; xi an yang sen yao pin an quan bu
shefali saini; xi an yang sen yao pin an quan bu
..............page:126-128
Rare Adverse Reactions of Statins
WANG Ruo-qi;WANG Yu-min
WANG Ruo-qi;WANG Yu-min
..............page:105-108
Organizing and Applying Good Safety Science Practices Throughout Drug Development and Commercialization
Kasia Petchel;Rebecca Wang;Gary Slatko;Daniel Reshef;Michael Peng;CHEN Yi-xin
Kasia Petchel;Rebecca Wang;Gary Slatko;Daniel Reshef;Michael Peng;CHEN Yi-xin
..............page:109-112
..............page:113-115
One Case of Disordered Vision Induced by Gatifloxacin
ZHANG Hai-feng;GUO Xin-tian
ZHANG Hai-feng;GUO Xin-tian
..............page:115-116
One Case of Anaphylactic Shock Induced by Ceftriaxone Sodium for Injection
CUI Xiang-li;ZHAO Yan;ZHAO Zhi-gang
CUI Xiang-li;ZHAO Yan;ZHAO Zhi-gang
..............page:116-117
Discussion on Drug Reevaluation by Analyzing Adverse Drug Reaction of Traditional Chinese Medicine Injection
BAI Xiao-ju
BAI Xiao-ju
..............page:86-90
Study of the Evaluation and Control for Quality of Adverse Drug Reaction Reports
TIAN Yue-jie;ZHOU Yong;HUANG Lin;FENG Qiao-qiao;XIE Yan-jun;KONG Qing-yan
TIAN Yue-jie;ZHOU Yong;HUANG Lin;FENG Qiao-qiao;XIE Yan-jun;KONG Qing-yan
..............page:90-95
..............page:96-99
Analysis of 36 Severe Low Blood Sugar Reactions of Xiaokewan
QU Yi;ZHANG Li
QU Yi;ZHANG Li
..............page:99-101
Analysis of 99 Reports of Adverse Events on Implantable Pacemaker
SHENG Hong-tao;CHEN Ai-min;CHEN Jian-feng;WANG Gang
SHENG Hong-tao;CHEN Ai-min;CHEN Jian-feng;WANG Gang
..............page:102-105
Suggestions on Drug Administration Law of People\'s Republic of China Amendment: Researching the System of Pharmacovigilance and Adverse Drug Reaction Monitoring
DONG Duo;WU Gui-zhi;TIAN Chun-hua;CHEN Yi-xin;LI Xin-ling;ZHANG Cheng-xu;WU Zhi-ang
DONG Duo;WU Gui-zhi;TIAN Chun-hua;CHEN Yi-xin;LI Xin-ling;ZHANG Cheng-xu;WU Zhi-ang
..............page:65-68
Analysis of the Position and Responsibility of Supervision Department in Pharmacovigilance and Drug Risk Management
ZHANG Hui-xia;LIU Chao;CHEN Jian-yu;ZHANG Wei-dong;FU Lin;LI Qing-fang;DONG Su-qiang;SHEN Lu
ZHANG Hui-xia;LIU Chao;CHEN Jian-yu;ZHANG Wei-dong;FU Lin;LI Qing-fang;DONG Su-qiang;SHEN Lu
..............page:69-73
Research on the Related Institution in the Construction of the Adverse Drug Reaction Monitoring System in China
GONG Pei-xian;KONG Qing-yan;ZHOU Yong;TIAN Yue-jie;HUANG Chuan-hai;XIE Yan-jun;HUANG Lin;FENG Qiao-qiao;WU Gui-zhi
GONG Pei-xian;KONG Qing-yan;ZHOU Yong;TIAN Yue-jie;HUANG Chuan-hai;XIE Yan-jun;HUANG Lin;FENG Qiao-qiao;WU Gui-zhi
..............page:74-79
Study on Hematuria Adverse Drug Reaction Induced by Cefradine for Injection
WANG Yan;HU Chang-qin;JIN Shao-hong
WANG Yan;HU Chang-qin;JIN Shao-hong
..............page:79-85